Season 1 · Episode 481
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
Motley Fool Money · LiSTNR
November 17, 202119m 53s
Audio is streamed directly from the publisher (enrichment.soundstack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!
See omnystudio.com/listener for privacy information.